Metal-on-Metal Hip Implants: AAOS, FDA Promote Physician and Patient Education

The U.S. Food and Drug Administration recently posted a public health communication about metal-on-metal hip components used during total hip arthroplasty aimed at informing physicians and patients about the concerns associated with the implants, according to the FDA website.

Advertisement

The American Academy of Orthopaedic Surgeons has also taken efforts to educate patients and surgeons about metal-on-metal hip implants. The organization asks patients who have already received MoM hip implants to tell their physicians about any new pain or symptoms they are experiencing. The organization is also part of the effort to establish the American Joint Replacement Registry to track data on outcomes and devices.

“The FDA is a partner in patient safety and education,” said John J. Callaghan, MD, president of AAOS. “We believe that a significant majority of metal-on-metal hip replacement implants have successfully relieved pain and improved function without any problems for the patients who have received them but there have been some concerning exceptions.”

Read the AAOS release on metal-on-metal hips implants.

View the FDA public health communications on hip implants.

Read other coverage on metal-on-metal hip implants:

– AAOS Supports Metal-on-Metal Hip Replacements But Urges Physicians to Educate Patients First

– 5 Reasons Why Controversy Surrounds Metal-on-Metal Hip Replacements

– Study: Metal-on-Metal Hip Replacement Could Have Long-Term Satisfactory Results

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.